Links to fda.gov from ismp.org

Relevant links pointing to domain from domain.

url / atext / target url	PR	score	semantic flow ™	on topic	referring domains	external backlinks
http://www.ismp.org/Tools/FDASafetyAlerts.asp pradaxa dabigatran etexilate mesylate drug safety communication safety review of post market reports of serious ↳http://www.fda.gov/Safety/MedWatch/SafetyInformation/SafetyAlertsforHumanMedicalProducts/u	0.16	0.99	1	no	0	0
http://www.ismp.org/Tools/FDASafetyAlerts.asp stimulant medication in children with ad hd communication about an ongoing safety review ↳http://www.fda.gov/Safety/MedWatch/SafetyInformation/SafetyAlertsforHumanMedicalProducts/u	0.16	0.99	1	no	0	0
http://www.ismp.org/Tools/FDASafetyAlerts.asp cefepime marketed as maxipime update of ongoing safety review ↳http://www.fda.gov/Safety/MedWatch/SafetyInformation/SafetyAlertsforHumanMedicalProducts/u	0.16	0.99	1	no	0	0
http://www.ismp.org/Tools/FDASafetyAlerts.asp potiga ezogabine drug safety communication linked to retinal abnormalities and blue skin discoloration ↳http://www.fda.gov/Safety/MedWatch/SafetyInformation/SafetyAlertsforHumanMedicalProducts/u	0.16	0.99	1	no	0	0
http://www.ismp.org/Tools/FDASafetyAlerts.asp inclusig ponatinib drug safety communication increased reports of serious blood clots in arteries and ↳http://www.fda.gov/Safety/MedWatch/SafetyInformation/SafetyAlertsforHumanMedicalProducts/u	0.16	0.99	1	no	0	0
http://www.ismp.org/Tools/FDASafetyAlerts.asp codeine cough and cold medicines in children drug safety communication fda evaluating potential risk of serious side ↳http://www.fda.gov/Safety/MedWatch/SafetyInformation/SafetyAlertsforHumanMedicalProducts/u	0.16	0.99	1	no	0	0
http://www.ismp.org/Tools/FDASafetyAlerts.asp low molecular weight heparins drug safety communication recommendations to decrease risk of spinal column bleeding ↳http://www.fda.gov/Safety/MedWatch/SafetyInformation/SafetyAlertsforHumanMedicalProducts/u	0.16	0.99	1	no	0	0
http://www.ismp.org/Tools/FDASafetyAlerts.asp testosterone products drug safety communication fda investigating risk of cardiovascular events ↳http://www.fda.gov/Safety/MedWatch/SafetyInformation/SafetyAlertsforHumanMedicalProducts/u	0.16	0.99	1	no	0	0
http://www.ismp.org/Tools/FDASafetyAlerts.asp duragesic fentanyl patches drug safety communication packaging changes to minimize risk of accidental ↳http://www.fda.gov/Safety/MedWatch/SafetyInformation/SafetyAlertsforHumanMedicalProducts/u	0.16	0.99	1	no	0	0
http://www.ismp.org/Tools/FDASafetyAlerts.asp genstrip blood glucose test strips by shasta technologies fda safety communication may report false ↳http://www.fda.gov/Safety/MedWatch/SafetyInformation/SafetyAlertsforHumanMedicalProducts/u	0.16	0.99	1	no	0	0

---

UPGRADE to see MORE results!